Why Biopas
One-Stop Solution Provider for all of Latin America
Biopas has developed a turnkey solution to accelerate growth of pharma companies in Latin America, as the “Partner of Choice” to launch and develop products in the region. Biopas is focused on de-risking these emerging markets territories, providing unmatched market access and revenue opportunities for its partners.
Biopas removes significant management disruption by eliminating complexity and time costs associated with doing business and closing deals on a country by country basis.
Biopas Capabilities
Support functions are operated under SAP platform with one single standard and audited by third parties
Marketing
Medical
Market Access
Patient Support Programs
Compliance
Regulatory & Quality
Supply Chain
Pharmacovigilance
- Specialized and dedicated sales force supported by a cross-functional team
- Strong company relationships with KOLs and through leadership position in therapeutical areas
- Unique and product specific sales technique adapted to visits through varying channels (face-to-face & digital)
- A digital marketing in-house agency allowing flexibility and agility in our communication
- Productivity analysis of marketing strategies, share of voice, and top of mind
Marketing
- Specialized and dedicated sales force supported by a cross-functional team
- Strong company relationships with KOLs and through leadership position in therapeutical areas
- Unique and product specific sales technique adapted to visits through varying channels (face-to-face & digital)
- A digital marketing in-house agency allowing flexibility and agility in our communication
- Productivity analysis of marketing strategies, share of voice, and top of mind
Medical
- Medical team with a scientific background: all MDs, geneticists, neurologists, pediatrician, among others
- Experts in developing medical education programs and pioneers in Real-World Data research in Latin America
- Strategic partnerships with healthcare institutions to become certificated Excellence Center in chronic diseases
Market Access
- Health Economics Research (HEOR) capabilities focused on Latam therapeutics guidelines
- Mastered the process to include new technologies in a wide range of payers
- Track-record of successful and innovative negotiations – strategies beyond price
Patient Support Programs
- In place regionally for Biopas key products
- Run by third parties ensuring compliance
- Audited frequently by third parties
Compliance
- Independent function reporting to the group CEO
- International standard – regional presence in all countries ensuring one single standard
- Clear compliance policies – UK Anti-bribery FCPA/anti-corruption policy, Interactions with healthcare professionals and public organizations, among others
- Audited frequently by third parties
Regulatory & Quality
- Holder of 600+ marketing authorizations and success in data protection and legal defence of IP
- Quality laboratory operated in Brazil and Argentina
- The very first LatAm company to obtain marketing approval for a cannabis derived medicinal product
- Quality Assurance System aligned and audited periodically, in accordance with the standards for the pharmaceutical industry established by EMA and FDA
Supply Chain
- Working with best-in-class suppliers trusted by multi-national pharmaceutical companies
- Warehousing outsourced through certified 3PLs
- Experience in the successful management of the cold chain
- Secondary packaging capabilities
- Audited frequently by third parties
Pharmacovigilance
- International standard – regional presence in all countries ensuring one single standard
- Audited frequently by partners and third parties
Biopas regional presence through own affiliates
